🧬 New Nature study: CMX410 shows promise as a novel TB drug targeting #Pks13, effective even against drug-resistant strains. This could help shorten long TB treatments.
🔗 www.nature.com/articles/s41...
#Tuberculosis #GlobalHealth #DrugDiscovery
Posts by MTBI
🚨 AI + digital X‑rays detect more TB in Mozambique prisons
A 2026 study found AI-assisted chest X‑rays outperformed symptom screening and improved linkage to treatment and preventive care, helping close diagnostic gaps.
🔗 bit.ly/3TBmoz
#Tuberculosis #Mozambique #GlobalHealth #AIinHealth #EndTB
🌎Colombia’s armed conflict fuels TB: more cases, more deaths. Displacement and disrupted care put communities at risk. We must keep health services running. 🔗 www.linkedin.com/posts/manhi%...
WHO has launched the 2026 World TB Day theme: “Yes! We can End TB!” The focus is stronger country leadership, increased investment, and faster rollout of new diagnostics. Ending TB is achievable with sustained action.
www.who.int/campaigns/wo...
#EndTB #PublicHealth
🦠 Anxiety is common in drug-sensitive TB but rarely addressed in routine care. A Pakistan study shows patients rely on self-coping, providers lack training, yet there’s strong support for integrated mental health care. Feasible model: sessions during TB visits.
🔗 link.springer.com/article/10.1...
TB doesn’t stay in prisons.
Prisons have TB rates 10–20× higher than the general population, with latent TB affecting ~40–50% of incarcerated people in many settings. These facilities act as reservoirs that fuel community transmission.
#TB #PublicHealth #PrisonHealth #GlobalHealth
🧪 #CRP testing for TB contacts: fingerprick = serum ✅
1,034 contacts studied using #LumiraDx: strong agreement, 77% sensitivity at WHO cutoff, serum storage -80°C didn’t affect results ❄️
Read study: www.sciencedirect.com/science/arti...
#Tuberculosis #TBScreening #GlobalHealth
⚠️ Flooding in Mozambique is disrupting transport and access to care. For people with TB, treatment interruptions raise serious risks. Our team is on the ground keeping TB services running. Every dose, every patient counts. #TBcare #FloodResponse #Mozambique
📍 Last week, MTBI joined the NUS–Lancet PRIME Commission on Pandemic Justice in Singapore, bringing together global experts to reimagine equitable, community-centered pandemic preparedness. Thanks to Helena Legido-Quigley, The Rt. Honorable Helen Clark, NUS & The Lancet Group!
#PublicHealth #TB
Seasonality of TB in Mozambique 📆
Globally, TB often peaks in spring/summer, but local patterns differ. In Maputo (2011–2016), TB notifications varied by quarter, yet models found no significant seasonal effect. Climate still shapes spatial TB risk nationwide.
#TB #Mozambique
💵 WHO warns that global progress against tuberculosis is at risk. TB still affects 10.7M people and causes over 1.2M deaths each year. Funding remains far below targets, threatening recent gains. Sustained investment is critical to end TB.
#EndTB #GlobalHealth #WHO
Happy Holidays and Happy New Year from the @mtbi.bsky.social team! Boas festas e um feliz ano novo! 🎆
❄️ As winter arrives in the Northern Hemisphere, it’s a good time to revisit the seasonality of tuberculosis. Research shows TB transmission may increase during winter months due to indoor crowding and reduced sunlight, with diagnoses peaking later.
pubmed.ncbi.nlm.nih.gov/21572609/
New research in Clinical Infectious Diseases: the AccuLAM study assesses the accuracy and added diagnostic value of TB-LAM for detecting TB in children without HIV, an important step toward improving pediatric TB diagnosis.
academic.oup.com/cid/advance-...
#Tuberculosis #GlobalHealth
During World Science Day for Peace and Development, Dr. Dinis Nguenha from CISM shared that using the #Truenat portable molecular diagnostic system enabled 82% of TB patients to start treatment on the same day of diagnosis, improving care and reducing delays!
👏 Dr. Belén Saavedra Cervera (ISGlobal & CISM) wowed audiences at the XXIX Jornadas sobre Tuberculosis 2025, presenting key findings on TB transmission in Manhiça through molecular epidemiology.
Thanks to #CoMB, #uiTB & #fuiTB!
🗨️ Our PhD student, Salome Valencia, presented today at the XXIX Jornadas Internacionales sobre Tuberculosis 2025, hosted by #CoMB, #uiTB & #fuiTB. She explored how armed conflict and social inequality shape #TB in Colombia. Grateful to all for fostering these vital discussions!
TB isn’t a disease of the past — it’s still one of the world’s top infectious killers (WHO, 2024).
❌ Not limited to certain countries
❌ A positive test ≠ contagious
✅ TB is curable, but stigma + myths slow progress.
#Tuberculosis #GlobalHealth
From new WHO guidance on TB & diabetes to innovations workshops, climate frameworks, and global commitments, 2025 is a pivotal year in the fight to #EndTB. Progress is happening, but action must continue. 🩺
#GlobalHealth
New meta-analysis finds no clear mortality benefit from intensified treatment regimens (ie. high-dose rifampicin, fluoroquinolones) for #tuberculous #meningitis in adults. More consistent, high-quality trials needed. 📚 pubmed.ncbi.nlm.nih.gov/41064692/
New study in PLOS ONE analyzes 255 messages between TB patients & treatment supporters using digital adherence tech (DATs).
Beyond reminders, patients need empathy, support & better usability.
📖 pubmed.ncbi.nlm.nih.gov/40705794/
#TB #mHealth #DigitalHealth
🩺New study compares 4R10 vs 2R20 regimens for latent TB. No major cost difference, but meds + follow-ups are biggest drivers. Fewer visits could cut costs, depending on setting.
🔗 pubmed.ncbi.nlm.nih.gov/40980570/
#TB #TPT #GlobalHealth #PublicHealth
🧬 TB remains one of the world’s top infectious killers.
Where, in your opinion, should innovation funding go next?
🟦 Diagnostics
🟦 Shorter treatments
🟦 Vaccines
🟦 Health systems
🌐 Read the WHO Global TB Report 2024: www.who.int/teams/global...
#TB #GlobalHealth #InfectiousDiseases #WHO
🩺 WHO now recommends a 6-month all-oral regimen for drug-resistant TB: shorter, safer, and easier to complete. A major step forward in global TB care.
📄 Full update: www.who.int/news/item/15...
#TB #GlobalHealth
🧠 UN: Children face a “new era of crisis.” For TB, this means more gaps in #care, fragile systems, and kids left behind. We can’t end #TB without reaching the most vulnerable.
🔗 news.un.org/en/story/202...
#EndTB #ChildHealth #GlobalHealth
❤️ On #WorldHeartDay, a reminder: #TB can affect more than lungs, it can influence hearts.
New research shows 1 in 5 patients with tuberculous pericarditis develop deadly heart failure post-surgery. Early care matters.
🔗 www.sciencedirect.com/science/arti...
#EndTB #HeartHealth
🩺 New Lancet study: Men are ~1.7x more likely than women to be infected w/ #TB due to biology and gendered factors.
Question for you: How can we design TB strategies that reflect real sex & gender differences without oversimplifying?
🔗 www.thelancet.com/journals/lan...
#GlobalHealth #HealthEquity
New NEJM study shows 3 oral, 9-month regimens are noninferior for rifampin-resistant #TB. A win for patient-centered care + policy updates.
🔗 www.nejm.org/doi/full/10....
#TB #GlobalHealth #HealthPolicy #InfectiousDisease
🧠Rethinking TB care: Integration isn’t a burden; it’s a cost-effective, people-centred strategy. A new @thelancet.com article makes the case for linking #TB, lung health & shared risks.
🔗 www.thelancet.com/journals/lan...
#Tuberculosis #LungHealth #GlobalHealth #PublicHealth #TheLancet
🧪 New stool #qPCR test improves pediatric #TB detection in high-burden settings! It's #non-invasive, has a high specificity, and improves pediatric TB detection where sputum or gastric sample collection is challenging.
🔗 academic.oup.com/jpids/articl...
#PediatricTB #GlobalHealth #Diagnostics